Conference 2011 Meningitis and Septicaemia in children and adults 2011

Meningitis and Septicaemia in children and adults 2011,Tuesday 8 and Wednesday 9 November 2011,Royal Society of Medicine, London, UK

Leading international experts will present the latest advances in prevention of these diseases, and issues in clinical management of bacterial meningitis and sepsis. The conference will bring together renowned scientists and clinicians from a range of specialties within both the paediatric and adult settings. These include infectious diseases, epidemiology, immunology, vaccinology, tropical medicine, microbiology, molecular medicine, emergency and critical care and rehabilitation medicine.

Plenary sessions over two days

Poster presentations

Satellite sessions sponsored by Pfizer and Novartis

Exhibition

Evening Wine Reception

Pfizer Session 17:00 Day 1

Preventing pneumococcal disease: Where have we come from and what does the future hold? - Dr Laura York, Senior Director, International Scientific and Clinical Affairs, Vaccines, Pfizer, France

Novartis Session 08:20 Day 2

Real lives, real costs; the toll of meningococcal disease - Chaired by Dr Peter Dull, Novartis Vaccines and Diagnostics, Cambridge, MA, USA

Immediate Impact: Musculo-skeletal impacts of meningococcal disease – Mr Fergal Monsell, Bristol Royal Hospital for Sick Children, UK

Societal impact: Psycho-social impacts of meningococcal disease – Dr Liam Dorris, Royal Hospital for Sick Children and University of Glasgow, Scotland

Public Health impact: Meningococcal disease outbreaks – Dr Stuart Clarke, University of Southampton, UK